Semi-Annual Statement Of Income And Retained Earnings

ASKA Pharmaceutical Holdings CO., Ltd. - Filing #7356776

Concept 2023-04-01 to
2023-12-31
2023-04-01 to
2023-12-31
2023-04-01 to
2023-12-31
2023-04-01 to
2023-12-31
2023-04-01 to
2023-12-31
2023-04-01 to
2023-12-31
2022-04-01 to
2022-12-31
2022-04-01 to
2022-12-31
2022-04-01 to
2022-12-31
2022-04-01 to
2022-12-31
2022-04-01 to
2022-12-31
2022-04-01 to
2022-12-31
Semi-annual statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
186,000,000 JPY
6,346,000,000 JPY
6,429,000,000 JPY
5,526,000,000 JPY
-103,000,000 JPY
-903,000,000 JPY
417,000,000 JPY
5,418,000,000 JPY
5,809,000,000 JPY
-767,000,000 JPY
5,041,000,000 JPY
-26,000,000 JPY
Non-operating income
Non-operating income
378,000,000 JPY
402,000,000 JPY
Non-operating expenses
Non-operating expenses
273,000,000 JPY
197,000,000 JPY
Ordinary profit (loss)
5,631,000,000 JPY
5,246,000,000 JPY
Extraordinary income
Extraordinary income
2,889,000,000 JPY
121,000,000 JPY
Profit (loss) before income taxes
8,520,000,000 JPY
5,367,000,000 JPY
Income taxes - current
2,151,000,000 JPY
1,036,000,000 JPY
Income taxes - deferred
-88,000,000 JPY
148,000,000 JPY
Profit (loss)
6,458,000,000 JPY
4,183,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.